STOCK TITAN

Agilent Names Allison Ballmer Senior Vice President of Strategy and Corporate Development

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags

Agilent Technologies Inc.(NYSE: A) is pleased to announce Allison Ballmer has been named the company’s new senior vice president of Strategy and Corporate Development, reporting to Agilent President and CEO Mike McMullen.

Ballmer will lead the corporate development team in identifying, developing, and evaluating merger-and-acquisition plans globally, as well as program management of integrations. She also will lead enterprise strategy while collaborating with Agilent businesses groups to drive critical growth initiatives across the company. Ballmer will serve as a key member of the executive staff and as an adviser to the CEO to help shape the company’s overall strategic direction.

"With nearly 20 years in the biotech industry — the last two being at Agilent — Allison brings a wealth of experience to this role. Her depth of knowledge in global business and marketing will serve Agilent well as we look to continue our Build-and-Buy growth strategy," McMullen said.

Prior to joining Agilent in May 2018 as vice president of Business Development and Strategy for the company’s Diagnostics and Genomics business, Ballmer spent nearly a decade of her career at Switzerland-based Roche, a multinational healthcare company that operates pharmaceutical and diagnostics divisions.

She currently holds the role of lead director of the board of directors at Mission Bio, a California venture-backed company focused on genomics and precision medicine.

Ballmer holds a Bachelor of Science in mechanical engineering from Virginia Polytechnic Institute and State University.

About Agilent Technologies

Agilent Technologies Inc. (NYSE: A) is a global leader in life sciences, diagnostics, and applied chemical markets, delivering insight and innovation toward improving the quality of life. Agilent instruments, software, services, solutions, and people provide trusted answers to customers' most challenging questions. The company generated revenue of $5.34 billion in fiscal year 2020 and employs 16,400 people worldwide. Information about Agilent is available at www.agilent.com. To receive the latest Agilent news, please subscribe to the Agilent Newsroom. Follow Agilent on LinkedIn, Twitter, and Facebook.

Agilent Technologies Inc.

NYSE:A

A Rankings

A Latest News

A Stock Data

Analytical Laboratory Instrument Manufacturing
Manufacturing
Link
Health Technology, Biotechnology, Medical Specialties, Professional, Scientific, and Technical Services, Testing Laboratories
US
Santa Clara

About A

analytical scientists and clinical researchers worldwide rely on agilent to help fulfill their most complex laboratory demands. our instruments, software, services and consumables address the full range of scientific and laboratory management needs—so our customers can do what they do best: improve the world around us. whether a laboratory is engaged in environmental testing, academic research, medical diagnostics, pharmaceuticals, petrochemicals or food testing, agilent provides laboratory solutions to meet their full spectrum of needs. we work closely with customers to help address global trends that impact human health and the environment, and to anticipate future scientific needs. our solutions improve the efficiency of the entire laboratory, from sample prep to data interpretation and management. customers trust agilent for solutions that enable insights...for a better world.